These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31418432)

  • 21. Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
    Jiang H; Shi X; Yu X; He X; An Y; Lu H
    Pharm Res; 2018 Feb; 35(4):73. PubMed ID: 29476264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
    Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
    Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
    Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
    Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
    Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
    Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
    Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer.
    Fang Y; Lin S; Yang F; Situ J; Lin S; Luo Y
    Biomed Res Int; 2020; 2020():9186583. PubMed ID: 32420382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Encapsulation of graphene quantum dot-crosslinked chitosan by carboxymethylcellulose hydrogel beads as a pH-responsive bio-nanocomposite for the oral delivery agent.
    Javanbakht S; Shaabani A
    Int J Biol Macromol; 2019 Feb; 123():389-397. PubMed ID: 30445077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides.
    Martins JP; Liu D; Fontana F; Ferreira MPA; Correia A; Valentino S; Kemell M; Moslova K; Mäkilä E; Salonen J; Hirvonen J; Sarmento B; Santos HA
    ACS Appl Mater Interfaces; 2018 Dec; 10(51):44354-44367. PubMed ID: 30525379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
    Cheng M; Han J; Li Q; He B; Zha B; Wu J; Zhou R; Ye T; Wang W; Xu H; Hou Y
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2035-43. PubMed ID: 22865703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
    Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
    Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
    Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
    Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo tissue distribution and safety of polyacrylic acid-modified titanium peroxide nanoparticles as novel radiosensitizers.
    Morita K; Suzuki T; Nishimura Y; Matsumoto K; Numako C; Sato K; Nakayama M; Sasaki R; Ogino C; Kondo A
    J Biosci Bioeng; 2018 Jul; 126(1):119-125. PubMed ID: 29428803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin-conjugated β-NaYF4:Gd(3+)/Tb(3+) multifunctional, phosphor nanorods: a multi-modal, luminescent, magnetic probe for simultaneous optical and magnetic resonance imaging and an excellent pH-triggered anti-cancer drug delivery nanovehicle.
    Padhye P; Alam A; Ghorai S; Chattopadhyay S; Poddar P
    Nanoscale; 2015 Dec; 7(46):19501-18. PubMed ID: 26538278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents.
    Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N
    J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug.
    Lo YL; Hsu CY; Lin HR
    J Drug Target; 2013 Jan; 21(1):54-66. PubMed ID: 23009351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.
    Choi KY; Jeon EJ; Yoon HY; Lee BS; Na JH; Min KH; Kim SY; Myung SJ; Lee S; Chen X; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    Biomaterials; 2012 Sep; 33(26):6186-93. PubMed ID: 22687759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
    Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
    J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.